BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

587 related articles for article (PubMed ID: 28423670)

  • 1. Invasive Fusobacterium nucleatum activates beta-catenin signaling in colorectal cancer via a TLR4/P-PAK1 cascade.
    Chen Y; Peng Y; Yu J; Chen T; Wu Y; Shi L; Li Q; Wu J; Fu X
    Oncotarget; 2017 May; 8(19):31802-31814. PubMed ID: 28423670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fusobacterium nucleatum Potentiates Intestinal Tumorigenesis in Mice via a Toll-Like Receptor 4/p21-Activated Kinase 1 Cascade.
    Wu Y; Wu J; Chen T; Li Q; Peng W; Li H; Tang X; Fu X
    Dig Dis Sci; 2018 May; 63(5):1210-1218. PubMed ID: 29508166
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Hu L; Liu Y; Kong X; Wu R; Peng Q; Zhang Y; Zhou L; Duan L
    Front Immunol; 2021; 12():658681. PubMed ID: 34093546
    [No Abstract]   [Full Text] [Related]  

  • 4. Fusobacterium nucleatum promotes M2 polarization of macrophages in the microenvironment of colorectal tumours via a TLR4-dependent mechanism.
    Chen T; Li Q; Wu J; Wu Y; Peng W; Li H; Wang J; Tang X; Peng Y; Fu X
    Cancer Immunol Immunother; 2018 Oct; 67(10):1635-1646. PubMed ID: 30121899
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Kong C; Yan X; Zhu Y; Zhu H; Luo Y; Liu P; Ferrandon S; Kalady MF; Gao R; He J; Yin F; Qu X; Zheng J; Gao Y; Wei Q; Ma Y; Liu JY; Qin H
    Cancer Res; 2021 Sep; 81(17):4485-4498. PubMed ID: 34162680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Invasive Fusobacterium nucleatum may play a role in the carcinogenesis of proximal colon cancer through the serrated neoplasia pathway.
    Yu J; Chen Y; Fu X; Zhou X; Peng Y; Shi L; Chen T; Wu Y
    Int J Cancer; 2016 Sep; 139(6):1318-26. PubMed ID: 27130618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fusobacterium nucleatum Increases Proliferation of Colorectal Cancer Cells and Tumor Development in Mice by Activating Toll-Like Receptor 4 Signaling to Nuclear Factor-κB, and Up-regulating Expression of MicroRNA-21.
    Yang Y; Weng W; Peng J; Hong L; Yang L; Toiyama Y; Gao R; Liu M; Yin M; Pan C; Li H; Guo B; Zhu Q; Wei Q; Moyer MP; Wang P; Cai S; Goel A; Qin H; Ma Y
    Gastroenterology; 2017 Mar; 152(4):851-866.e24. PubMed ID: 27876571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fusobacterium nucleatum-triggered neutrophil extracellular traps facilitate colorectal carcinoma progression.
    Kong X; Zhang Y; Xiang L; You Y; Duan Y; Zhao Y; Li S; Wu R; Zhang J; Zhou L; Duan L
    J Exp Clin Cancer Res; 2023 Sep; 42(1):236. PubMed ID: 37684625
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Rubinstein MR; Baik JE; Lagana SM; Han RP; Raab WJ; Sahoo D; Dalerba P; Wang TC; Han YW
    EMBO Rep; 2019 Apr; 20(4):. PubMed ID: 30833345
    [No Abstract]   [Full Text] [Related]  

  • 10. Fusobacterium nucleatum promotes chemoresistance to 5-fluorouracil by upregulation of BIRC3 expression in colorectal cancer.
    Zhang S; Yang Y; Weng W; Guo B; Cai G; Ma Y; Cai S
    J Exp Clin Cancer Res; 2019 Jan; 38(1):14. PubMed ID: 30630498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein Kinase C-ζ stimulates colorectal cancer cell carcinogenesis via PKC-ζ/Rac1/Pak1/β-Catenin signaling cascade.
    Islam SMA; Patel R; Acevedo-Duncan M
    Biochim Biophys Acta Mol Cell Res; 2018 Apr; 1865(4):650-664. PubMed ID: 29408512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intratumoral Fusobacterium nucleatum abundance correlates with macrophage infiltration and CDKN2A methylation in microsatellite-unstable colorectal carcinoma.
    Park HE; Kim JH; Cho NY; Lee HS; Kang GH
    Virchows Arch; 2017 Sep; 471(3):329-336. PubMed ID: 28597080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Rac1/PAK1 cascade controls β-catenin activation in colon cancer cells.
    Zhu G; Wang Y; Huang B; Liang J; Ding Y; Xu A; Wu W
    Oncogene; 2012 Feb; 31(8):1001-12. PubMed ID: 21822311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphorylation of β-catenin at serine 663 regulates its transcriptional activity.
    Park MH; Kim DJ; You ST; Lee CS; Kim HK; Park SM; Shin EY; Kim EG
    Biochem Biophys Res Commun; 2012 Mar; 419(3):543-9. PubMed ID: 22369945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between
    Proença MA; Biselli JM; Succi M; Severino FE; Berardinelli GN; Caetano A; Reis RM; Hughes DJ; Silva AE
    World J Gastroenterol; 2018 Dec; 24(47):5351-5365. PubMed ID: 30598580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Banxia Xiexin Decoction delays colitis-to-cancer transition by inhibiting E-cadherin/β-catenin pathway via Fusobacterium nucleatum FadA.
    Jiang Y; Huang Y; Hu Y; Yang Y; You F; Hu Q; Li X; Zhao Z
    J Ethnopharmacol; 2024 Jun; 328():117932. PubMed ID: 38382652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fusobacterium nucleatum induces oxaliplatin resistance by inhibiting ferroptosis through E-cadherin/β-catenin/GPX4 axis in colorectal cancer.
    Li B; Wei Z; Wang Z; Xu F; Yang J; Lin B; Chen Y; Wenren H; Wu L; Guo X; Liu Y; Wei Y
    Free Radic Biol Med; 2024 Aug; 220():125-138. PubMed ID: 38657754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Fusobacterium nucleatum infection with colorectal cancer in Chinese patients.
    Li YY; Ge QX; Cao J; Zhou YJ; Du YL; Shen B; Wan YJ; Nie YQ
    World J Gastroenterol; 2016 Mar; 22(11):3227-33. PubMed ID: 27004000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Highly sensitive stool DNA testing of Fusobacterium nucleatum as a marker for detection of colorectal tumours in a Japanese population.
    Suehiro Y; Sakai K; Nishioka M; Hashimoto S; Takami T; Higaki S; Shindo Y; Hazama S; Oka M; Nagano H; Sakaida I; Yamasaki T
    Ann Clin Biochem; 2017 Jan; 54(1):86-91. PubMed ID: 27126270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-135b Aggravates Fusobacterium nucleatum-Induced Cisplatin Resistance in Colorectal Cancer by Targeting KLF13.
    Zeng W; Pan J; Ye G
    J Microbiol; 2024 Feb; 62(2):63-73. PubMed ID: 38402337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.